Cellebrite Shareholders Approve All Proposals at AGM
Ticker: CLBT · Form: 6-K · Filed: Sep 19, 2024 · CIK: 1854587
| Field | Detail |
|---|---|
| Company | Cellebrite Di Ltd. (CLBT) |
| Form Type | 6-K |
| Filed Date | Sep 19, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
TL;DR
Cellebrite AGM: Shareholders said YES to everything.
AI Summary
Cellebrite DI Ltd. announced that its shareholders approved all proposals at the annual general meeting held on September 17, 2024. The approvals were made by the requisite majority as per Israeli Companies Law and the company's articles of association.
Why It Matters
Shareholder approval of all proposals at the annual general meeting ensures the company can proceed with its planned corporate actions and governance.
Risk Assessment
Risk Level: low — This filing is a routine announcement of shareholder meeting outcomes and does not introduce new financial or operational risks.
Key Players & Entities
- Cellebrite DI Ltd. (company) — Registrant
- September 17, 2024 (date) — Date of Annual General Meeting
- Israeli Companies Law, 5759-1999 (legal_document) — Governing Law for Approvals
FAQ
What was the date of Cellebrite DI Ltd.'s annual general meeting?
The annual general meeting of shareholders was held on September 17, 2024.
Were all proposals approved at the meeting?
Yes, all proposals brought before the annual general meeting were approved by the shareholders.
Under which law were the shareholder approvals made?
The approvals were made in accordance with the Israeli Companies Law, 5759-1999.
What is the company's principal executive office address?
The principal executive office is located at 94 Shlomo Shmelzer Road, Petah Tikva 4970602, Israel.
Does Cellebrite DI Ltd. file annual reports under Form 20-F or 40-F?
Cellebrite DI Ltd. files annual reports under Form 20-F.
Filing Stats: 325 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-09-19 16:01:26
Filing Documents
- ea0215076-6k_cellebrite.htm (6-K) — 10KB
- 0001213900-24-080259.txt ( ) — 11KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellebrite DI Ltd. September 19, 2024 By: /s / Ayala Berler Shapira Ayala Berler Shapira General Counsel 2